Paper498174
Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report.
Alberts DS and 4 others. Cancer Treat Rev, 1979. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Papers, record 498174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/498174
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorambucil | Major topic |
| Leukemia, Lymphoid | Major topic |
| Lymphoma | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Intestinal Absorption | |
| Male | |
| Metabolic Clearance Rate | |
| Middle Aged |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36155936 | Population pharmacokinetics identifies rapid gastrointestinal absorption and plasma clearance of oral chlorambucil administered to cats with indolent lymphoproliferative malignancies. | Am J Vet Res | 2022 | https://conductscience.org/library/papers/36155936 | PubMed |
| 30192852 | In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs. | PLoS One | 2018 | https://conductscience.org/library/papers/30192852 | PubMed |
| 23585833 | Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism. | PLoS One | 2013 | https://conductscience.org/library/papers/23585833 | PubMed |
| 16430310 | Mass balance studies, with a focus on anticancer drugs. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16430310 | PubMed |
| 7460189 | Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7460189 | PubMed |
| 7272193 | British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7272193 | PubMed |
| 6791675 | In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6791675 | PubMed |
| 6489421 | Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6489421 | PubMed |
| 3069479 | Inter- and intraindividual differences in oral chlorambucil pharmacokinetics. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3069479 | PubMed |
| 2191847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/498174
GET https://conductscience.org/api/papers/v1/498174/authors